Pfizer: Safety Profile of Sasanlimab Was Generally Consistent With Known Profile of Bcg & Data Reported From Clinical Trials
辉瑞:Sasanlimab的安全性概况与已知的BcG概况及临床试验中报告的数据一致。
Pfizer: Safety Profile of Sasanlimab Was Generally Consistent With Known Profile of Bcg & Data Reported From Clinical Trials
辉瑞:Sasanlimab的安全性概况与已知的BcG概况及临床试验中报告的数据一致。
使用浏览器的分享功能,分享给你的好友吧